- Report
- August 2022
- 327 Pages
Global
From €3176EUR$3,600USD£2,771GBP
- Report
- October 2025
- 92 Pages
Qatar
From €4278EUR$4,850USD£3,733GBP
- Report
- September 2025
- 96 Pages
Germany
From €4278EUR$4,850USD£3,733GBP
- Book
- September 2025
- 488 Pages
From €353EUR$400USD£308GBP
- Report
- December 2024
- 51 Pages
Global
From €2204EUR$2,499USD£1,923GBP
- Report
- August 2024
- 41 Pages
Global
From €878EUR$995USD£766GBP
- Report
- July 2024
- 105 Pages
Asia Pacific
From €3043EUR$3,450USD£2,655GBP
- Report
- July 2024
- 221 Pages
Global
From €4367EUR$4,950USD£3,810GBP
- Report
- June 2023
- 62 Pages
Global
From €1720EUR$1,950USD£1,501GBP
- Report
- June 2020
- 464 Pages
Global
From €4323EUR$4,900USD£3,771GBP
- Report
- October 2023
- 95 Pages
Global
From €3500EUR$4,250USD£3,161GBP
- Book
- June 2020
- 198 Pages
The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more
